S.R. Schill & Associates’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,512
Closed -$253K 65
2024
Q2
$253K Buy
4,512
+810
+22% +$45.3K 0.11% 71
2024
Q1
$217K Sell
3,702
-78
-2% -$4.41K 0.09% 79
2023
Q4
$204K Buy
+3,780
New +$185K 0.09% 82
2023
Q3
Sell
-4,807
Closed -$271K 84
2023
Q2
$271K Buy
4,807
+263
+6% +$14.5K 0.12% 67
2023
Q1
$245K Sell
4,544
-565
-11% -$30.1K 0.11% 71
2022
Q4
$269K Sell
5,109
-177
-3% -$8.98K 0.13% 63
2022
Q3
$249K Buy
5,286
+74
+1% +$3.84K 0.13% 63
2022
Q2
$263K Sell
5,212
-4,383
-46% -$239K 0.13% 57
2022
Q1
$585K Buy
9,595
+200
+2% +$11.9K 0.25% 34
2021
Q4
$619K Buy
9,395
+226
+2% +$14.5K 0.25% 36
2021
Q3
$576K Sell
9,169
-59
-0.6% -$3.76K 0.25% 42
2021
Q2
$555K Sell
9,228
-126
-1% -$7.29K 0.22% 48
2021
Q1
$515K Buy
9,354
+924
+11% +$51.2K 0.23% 46
2020
Q4
$460K Buy
8,430
+4,284
+103% +$224K 0.21% 48
2020
Q3
$207K Buy
+4,146
New +$201K 0.11% 72
2020
Q1
Sell
-33,042
Closed -$1.46M 77
2019
Q4
$1.46M Sell
33,042
-7,878
-19% -$331K 0.79% 25
2019
Q3
$1.69M Buy
40,920
+3,156
+8% +$129K 0.94% 21
2019
Q2
$1.51M Sell
37,764
-58,044
-61% -$2.2M 0.94% 22
2019
Q1
$3.7M Buy
95,808
+21,294
+29% +$773K 2.23% 11
2018
Q4
$2.48M Buy
74,514
+2,526
+4% +$87.5K 1.74% 13
2018
Q3
$2.73M Buy
+71,988
New +$2.56M 1.68% 16

Other funds holding IHI

S.R. Schill & Associates's IHI Position: Q3 2024 in Review

S.R. Schill & Associates sold out of iShares US Medical Devices ETF (IHI) in Q3 2024, closing a stake of 4,512 shares — an estimated $253K sold.

S.R. Schill & Associates first reported a position in IHI in Q3 2018 and held it in 21 quarters. The position peaked at $3.7M in Q1 2019. 554 funds tracked by Wall St. Rank hold IHI as of Q3 2024.

  • S.R. Schill & Associates reported no remaining iShares US Medical Devices ETF position as of Q3 2024 after selling out during the quarter.
  • S.R. Schill & Associates sold 4,512 iShares US Medical Devices ETF shares in Q3 2024, an estimated $253K.
  • S.R. Schill & Associates first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 21 quarters.
  • S.R. Schill & Associates's iShares US Medical Devices ETF position peaked at $3.7M in Q1 2019.
  • 554 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2024.

Based on S.R. Schill & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.